97 related articles for article (PubMed ID: 1534414)
1. Further evidence for the mechanisms that may mediate nicotine discrimination.
Schechter MD; Meehan SM
Pharmacol Biochem Behav; 1992 Apr; 41(4):807-12. PubMed ID: 1534414
[TBL] [Abstract][Full Text] [Related]
2. Effect of altering dopamine or serotonin neurotransmitters upon cathinone discrimination.
Schechter MD
Pharmacol Biochem Behav; 1992 Jan; 41(1):37-41. PubMed ID: 1347176
[TBL] [Abstract][Full Text] [Related]
3. Cocaine discrimination is attenuated by isradipine and CGS 10746B.
Schechter MD
Pharmacol Biochem Behav; 1993 Mar; 44(3):661-4. PubMed ID: 8095726
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus properties of isradipine: effect of other calcium channel blockers.
Schechter MD
Pharmacol Biochem Behav; 1995 Apr; 50(4):539-43. PubMed ID: 7617699
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus properties of CGS 10746B: similarity to dopamine D1 receptor antagonists.
Meehan SM; Schechter MD
Behav Brain Res; 1996 Jan; 74(1-2):199-205. PubMed ID: 8851930
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic mediation of the stimulant generalization of nicotine.
Schechter MD; Meehan SM
Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):835-45. PubMed ID: 7902994
[TBL] [Abstract][Full Text] [Related]
8. P and NP rats respond differently to the discriminative stimulus effects of nicotine.
Gordon TL; Meehan SM; Schechter MD
Pharmacol Biochem Behav; 1993 Jun; 45(2):305-8. PubMed ID: 8327536
[TBL] [Abstract][Full Text] [Related]
9. CGS 10746B is able to attenuate the effects of amphetamine: further evidence for dopaminergic mediation.
Schechter MD; Boja JW
Pharmacol Biochem Behav; 1988 Aug; 30(4):1089-92. PubMed ID: 2906435
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic treatment with the calcium entry blocker, isradipine, on vascular calcium overload produced by vitamin D3 and nicotine in rats.
Henrion D; Chillon JM; Capdeville-Atkinson C; Atkinson J
J Pharmacol Exp Ther; 1992 Jan; 260(1):1-8. PubMed ID: 1309868
[TBL] [Abstract][Full Text] [Related]
11. Effects of the dopamine release inhibitor, CGS 10746B, on the locomotor stimulant and discriminative stimulus effects of cocaine and methamphetamine.
French D; Witkin JM
Pharmacol Biochem Behav; 1993 Dec; 46(4):989-93. PubMed ID: 8309980
[TBL] [Abstract][Full Text] [Related]
12. Effect of learned behavior upon conditioned place preference to cathinone.
Schechter MD
Pharmacol Biochem Behav; 1991 Jan; 38(1):7-11. PubMed ID: 1673251
[TBL] [Abstract][Full Text] [Related]
13. Effects of L-type voltage-sensitive calcium channel modulators on the discriminative stimulus effects of ethanol in rats.
Green KL; Grant KA
Alcohol Clin Exp Res; 1999 May; 23(5):806-14. PubMed ID: 10371399
[TBL] [Abstract][Full Text] [Related]
14. Scopolamine-physostigmine combination does not substitute for nicotine.
Schechter MD
Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):499-508. PubMed ID: 7624500
[TBL] [Abstract][Full Text] [Related]
15. Isradipine inhibits nicotine intravenous self-administration in drug-naive mice.
Martellotta MC; Kuzmin A; Zvartau E; Cossu G; Gessa GL; Fratta W
Pharmacol Biochem Behav; 1995 Oct; 52(2):271-4. PubMed ID: 8577790
[TBL] [Abstract][Full Text] [Related]
16. Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release.
Carboni E; Acquas E; Frau R; Di Chiara G
Eur J Pharmacol; 1989 May; 164(3):515-9. PubMed ID: 2767122
[TBL] [Abstract][Full Text] [Related]
17. A dihydropyridine-resistant component in the rat adrenal secretory response to splanchnic nerve stimulation.
López MG; Shukla R; García AG; Wakade AR
J Neurochem; 1992 Jun; 58(6):2139-44. PubMed ID: 1374118
[TBL] [Abstract][Full Text] [Related]
18. Dopamine mechanisms play at best a small role in the nicotine discriminative stimulus.
Corrigall WA; Coen KM
Pharmacol Biochem Behav; 1994 Jul; 48(3):817-20. PubMed ID: 7938142
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic nature of acute cathine tolerance.
Schechter MD
Pharmacol Biochem Behav; 1990 Aug; 36(4):817-20. PubMed ID: 1977178
[TBL] [Abstract][Full Text] [Related]
20. Conditioned place aversion following the central administration of a novel dopamine release inhibitor CGS 10746B.
Calcagnetti DJ; Schechter MD
Pharmacol Biochem Behav; 1991 Oct; 40(2):255-9. PubMed ID: 1687164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
